Table 1.
VOC | Dose (mmol/kg) | P-450 | CYP2E1 | Lipid peroxidation | GSH | MNPCE | CA | Reference |
---|---|---|---|---|---|---|---|---|
DCM | 2.5 | 0 | 0 | 0 | 0 | Pilot study | ||
CLF | 2.6 | 0 | +0.48 | 0 | 0 | Pilot study | ||
TOL | 8 | −0.48 | +0.50 | 0 | 0 | Pilot study | ||
| ||||||||
DCM | 1.2–2.4 | 0 | 0 | [23] | ||||
4.8–9.5 | +0.4–0.50 | +0.35 | [23] | |||||
6 | 0 | [24] | ||||||
5–20 | 0 | [25] | ||||||
1.2–23.5 | 0 | [26] | ||||||
| ||||||||
CLF | 0.1 | 0 | [27] | |||||
1.3 | 0 | 0 | 0 | [28] | ||||
1.7 | −0.07 | [27] | ||||||
2.0–8.0 | 0 | [25] | ||||||
0.01 | +3.75 | [21] | ||||||
0.1–1.0 | +7.75 | [21] | ||||||
| ||||||||
TOL | 5 | 0 | +1.16 | [29] | ||||
5.4 | 0 | [9] | ||||||
10.8 | +0.30 | [9] | ||||||
16.2 | +0.17 | [9] | ||||||
20 | 0 | [30] | ||||||
1.2 | 0 | 0 | [31] | |||||
2.4 | +0.32 | 0 | [31] | |||||
4.7 | 0 | +2.71 | [31] |
Data represent significant fold increases (+) or decreases (−) with respect to control animals; zero means no change.
Cytochrome P450 (P-450), cytochrome 2E1 (CYP2E1), lipid peroxidation and glutathione (GSH) were determined in liver, micronuclei (MNPCE) and chromosomal aberrations (CA) were determined in bone marrow.